Every pharma commercial leader I talk to says some version of the same thing: "We have more data than we know what to do with, and we can't answer basic questions about our customers." The data is there — in CRM systems, in claims databases, in third-party market research, in digital engagement logs, in call center records, in speaker program attendance sheets. The problem is that none of it is connected in a way that generates coherent insight.
This is the data silo problem, and it is the root cause of most of the commercial execution failures I've seen in this industry.
Why Silos Persist
Data silos in life sciences commercial aren't an accident — they're the accumulated result of decades of point-solution purchasing. A CRM here, a marketing automation platform there, a market data subscription that IT manages, a patient services system that commercial operations owns. Each system solved a problem when it was bought. Nobody planned the integration because integration wasn't the priority; capability was.
Layer on top of that the organizational dynamics: field force data belongs to commercial operations, digital engagement data belongs to digital marketing, claims data is managed by market access or managed care, patient support data lives in medical affairs. Each team has its own KPIs, its own vendor relationships, and often its own budget. Sharing data across these boundaries requires governance and trust that takes years to build.
The data silo problem isn't technical at its root. It's organizational — and solving it requires treating data as a shared commercial asset, not a departmental resource.
What a Connected Data Foundation Enables
When commercial data is integrated — not perfectly, but well enough — three things become possible. First, you can build a coherent picture of how each HCP or patient segment moves through the engagement journey. Second, you can measure the true impact of different channel combinations, not just individual channel performance in isolation. Third, you can begin to apply AI and predictive analytics in ways that actually have commercial relevance, because the models have access to the full context of customer behavior.
The ROI of connected data isn't abstract. I've seen companies reduce wasted promotional spend by 20-30% simply by understanding which HCPs were already high-decile prescribers getting over-called by the field. I've seen patient identification programs accelerate time-to-therapy by identifying key diagnostic inflection points in claims data that nobody was tracking. These outcomes require connected data. They are simply not possible in a silo environment.
A Pragmatic Starting Point
The instinct when faced with a data silo problem is to propose a massive data modernization program — a new data lake, a customer data platform, a full-stack overhaul. Sometimes that's right. Often it's not, because it takes too long, costs too much, and loses organizational momentum before any value is delivered.
A more pragmatic approach: identify the two or three commercial questions that matter most to your business right now, and work backward to understand what data, connected in what way, would let you answer them. Build a minimum viable data integration for those questions. Demonstrate value quickly. Then use that win to fund the next layer of integration.
Data infrastructure is never done. The goal isn't a perfect architecture — it's a continuous improvement process that keeps pace with commercial ambition. Start with the question that matters most, connect just enough data to answer it well, and build from there.
Struggling to make sense of your commercial data?
I help life science companies define the data strategy and integration architecture that unlocks real commercial insight — without boiling the ocean.
Start the conversation →